Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.

Autor: von der Möhlen MA; Academic Medical Center, Laboratory of Experimental Internal Medicine, University of Amsterdam, Amsterdam, The Netherlands., van der Poll T, Jansen J, Levi M, van Deventer SJ

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 1996 Jun 15; Vol. 156 (12), pp. 4969-73.

Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).

Autor: von der Möhlen MA; Center of Thrombosis, Hemostasis, Atherosclerosis and Inflammation Research, Academic Medical Center, Amsterdam, The Netherlands., van Deventer SJ, Levi M, van den Ende B, Wedel NI, Nelson BJ, Friedmann N, ten Cate JW

Publikováno v: Blood [Blood] 1995 Jun 15; Vol. 85 (12), pp. 3437-43.

Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.

Autor: van Beek EJ; Center for Haemastasis, Thrombosis, Atherosclerosis and Inflammation Research, University of Amsterdam, Netherlands., von der Möhlen MA, ten Cate JW, Brandjes DP, Büller HR

Publikováno v: The Netherlands journal of medicine [Neth J Med] 1994 Nov; Vol. 45 (5), pp. 206-10.

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

Autor: Wortel CH; Department of Gastroenterology, University of Amsterdam, Netherlands., von der Möhlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW

Publikováno v: The Journal of infectious diseases [J Infect Dis] 1992 Dec; Vol. 166 (6), pp. 1367-74.